<i>Oligonucleotides</i> (IMAGE)

Mary Ann Liebert, Inc./Genetic Engineering News

<i>Oligonucleotides</i>

Caption

Oligonucleotides, edited by John Rossi, Ph.D., and C.A. Stein, M.D., Ph.D., from the Department of Oncology at Albert Einstein-Montefiore Cancer Center, is an authoritative, peer-reviewed journal published 6 times a year in print and online that focuses on synthetic oligonucleotides, including RNA, DNA, and ribozymes, and their effects on gene expression at the RNA and DNA levels both in vitro and in vivo. It represents a forum for basic research and applied therapeutics for the purpose of developing new concepts and experimental approaches to understanding and modulating gene activity. Oligonucleotides is the official journal of the Oligonucleotide Therapeutics Society (http://www.myots.org). Tables of content and a free sample issue may be viewed online at www.liebertpub.com/oli.

Credit

Mary Ann Liebert Inc., publishers

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.